OTC - ACTIVE INGREDIENT SECTION
Active ingredients Purpose
Avobenzone 3% Sunscreen
Homosalatate 10% Sunscreen
Octisalate 5% Sunscreen
Octocrylene 7% Sunscreen
Active ingredients Purpose
Avobenzone 3% Sunscreen
Homosalatate 10% Sunscreen
Octisalate 5% Sunscreen
Octocrylene 7% Sunscreen
Uses
helps prevent sunburn
If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Keep out of children. If swallowed, get medical help or contact a Poison Control Center right away.
Stop use and ask a doctor if rash occurs
Warnings
For external Use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Directions
apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
reapply at least every 2 hours
Children under 6 months: ask a doctor
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
limit time in the sun, especially 10a.m. - 2 p.m.
wear long-sleeve shirts, pants, hats and sunglasses
Inactive ingredients
Water/Aqua, Styrene/Acrylates Copolymer, Glyceryl Stearate, PEG-100 Stearate, Aluminum Starch Octenylsuccinate, Lauroyl Lysine, Arachidyl Alcohol, Behenyl Alcohol, Arachidyl Glucoside,Ethylhexylglycerin, Benzyl Alcohol, Bisabolol, Royal Jelly, Cyclopentasiloxane, Acrylates/Dimethicone Copolymer, Cocos Nucifera, Moringa Oleifera, Fragrance/Parfum, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Disodium EDTA, Allantoin, Arginine, Chlorphenesin, Cichorium Intybus (Chicory) Root Extract, Kappaphycus Alvarezii Extract, Glycerin, Polygonum Aviculare Extract, Sodium Ascorbyl Phosphate, Benzyl Salicylate, Limonene, Hydroxycitronellal, Butylphenyl Methylpropional (Lillial), Linalool
Jafra Royal Jelly
Total Content 30 ml 1 FL OZ
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68828-242-01 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-75a8-a426-e053-dadaa90af4c2 | Jafra Royal Jelly Kit |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68828-242-01 | Royal Jelly KitJafra | 1 in 1 KIT | KIT | 1 | 4 | |
| 68828-243-01 | Royal Jelly KitJafra | 15 mL in 1 BOTTLE | CREAM | 15 mL | 7 g in 100mL | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68828-242 | ROYAL JELLY KIT JAFRA (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) KIT [JAFRA COSMETICS INTERNATIONAL] | 4 | Legacy NDC, 2 package rows | 20200623_6a43d4d4-e372-4e73-8a7f-2af85d6efa73.zip |
| 68828-243 | ROYAL JELLY KIT JAFRA (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) KIT [JAFRA COSMETICS INTERNATIONAL] | 4 | Unmatched | 20200623_6a43d4d4-e372-4e73-8a7f-2af85d6efa73.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68828-243 | 68828-243-01 |
| 68828-242 | 68828-242-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a8b4552e-7510-3f87-e053-2a95a90ae58f | 6a43d4d4-e372-4e73-8a7f-2af85d6efa73 | 2020-06-22 | Warnings | a8b4552e-7510-3f87-e053-2a95a90ae58f 6a43d4d4-e372-4e73-8a7f-2af85d6efa73 |
Adverse event summaries are temporarily unavailable. Other product information remains available.